MMP-9-IN-1
CAS No. 502887-71-0
MMP-9-IN-1 ( —— )
产品货号. M21587 CAS No. 502887-71-0
MMP-9-IN-1 是特定基质金属蛋白酶-9 (MMP-9) 的抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥591 | 有现货 |
|
| 5MG | ¥938 | 有现货 |
|
| 10MG | ¥1568 | 有现货 |
|
| 25MG | ¥3060 | 有现货 |
|
| 50MG | ¥4399 | 有现货 |
|
| 100MG | ¥5931 | 有现货 |
|
| 200MG | ¥8001 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1074 | 有现货 |
|
生物学信息
-
产品名称MMP-9-IN-1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述MMP-9-IN-1 是特定基质金属蛋白酶-9 (MMP-9) 的抑制剂。
-
产品描述MMP-9-IN-1 is an inhibitor of specific matrix metalloproteinase-9 (MMP-9).
-
体外实验MMP-9-IN-1 (compound 2; 100 μM; 14 hours) does not cause notable cytotoxicity.MMP-9-IN-1 (compound 2; 10 μM) significantly inhibits cell proliferation of HT-1080 and MDA-MB-435 cells. Cell Cytotoxicity Assay Cell Line:COS-1 monkey epithelial cell lines Concentration:100 μM Incubation Time:24 hours Result:Treatment did not cause notable cytotoxicity. Cell Proliferation Assay Cell Line:HT-1080 and MDA-MB-435 cancer cells expressing endogenous MMP-9Concentration:10 μM Incubation Time:9 days Result:Significant inhibition of cell proliferation.
-
体内实验MMP-9-IN-1 (compound 2; 20 mg/kg; intraperitoneal and intratumoral injection alternately; 6 days/week; for 14 weeks) results in a profound delay in tumor growth in NCR-Nu mice bearing MDA-MB-435/GFP tumor. MMP-9-IN-1 inhibits cancer cell metastasis in vivo. Animal Model:4-5 week-old female NCR-Nu mice bearing MDA-MB-435/GFP tumorDosage:20 mg/kg Administration:Intraperitoneal and intratumoral injection alternately; 6 days/week; for 14 weeks,Result:Resulted in a profound delay in tumor growth.Inhibited cancer cell metastasis.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点MMP
-
受体MMP-9
-
研究领域——
-
适应症——
化学信息
-
CAS Number502887-71-0
-
分子量369.39
-
分子式C16H17F2N3O3S
-
纯度>98% (HPLC)
-
溶解度DMSO:125 mg/mL (338.40 mM; Need ultrasonic)
-
SMILESCCCc1cc(=O)[nH]c(SCC(=O)Nc2ccc(OC(F)F)cc2)n1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Dufour A et al. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9. Cancer Res. 2011 Jul 15;71(14):4977-88.
产品手册
关联产品
-
Aderamastat
Aderamastat (FP-025) 是一种口服活性基质金属蛋白酶 12 (MMP-12) 抑制剂。Aderamastat 可用于哮喘、慢性阻塞性肺病 (COPD) 和肺纤维化的研究。
-
Colistimethate Sodiu...
粘菌素钠用于治疗治疗选择有限的患者因选定的需氧革兰氏阴性病原体引起的严重感染。
-
MMP-2/MMP-9 Inhibito...
MMP-2/MMP-9-IN-1 是一种具有口服有效的高选择性 IV 型胶原酶 (MMP-9 和 MMP-2) 抑制剂,对 MMP-9 和 MMP-2 的 IC50 分别为 0.24 和 0.3 1μM。MMP-2/MMP-9-IN-1 在动物模型中抑制肿瘤生长和转移,可用于癌症研究。
021-51111890
购物车()
sales@molnova.cn

